• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下尿路症状、肥胖与代谢综合征。

Lower urinary tract symptoms, obesity and the metabolic syndrome.

机构信息

Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611-3008, USA.

出版信息

Curr Opin Urol. 2010 Jan;20(1):7-12. doi: 10.1097/MOU.0b013e3283336f3f.

DOI:10.1097/MOU.0b013e3283336f3f
PMID:19904208
Abstract

PURPOSE OF REVIEW

The epidemic of obesity and concomitant metabolic syndrome is well documented. New evidence points to a connection between the components of metabolic syndrome and benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

RECENT FINDINGS

Multiple studies have demonstrated a strong independent association between the components of metabolic syndrome and BPH/LUTS. Furthermore, modifiable risk factors, such as increased physical activity, appear to decrease the risk of BPH/LUTS.

SUMMARY

Emerging data points to a strong relationship between metabolic syndrome and BPH/LUTS, indicating a common cause. Further exploration of this relationship may result in a new understanding of the pathophysiology, treatment, and prevention of these disorders.

摘要

目的综述

肥胖症和随之而来的代谢综合征的流行已得到充分证实。新的证据表明,代谢综合征的组成部分与良性前列腺增生(BPH)和下尿路症状(LUTS)之间存在联系。

最近的发现

多项研究表明,代谢综合征的组成部分与 BPH/LUTS 之间存在强烈的独立关联。此外,可改变的危险因素,如增加身体活动,似乎可以降低 BPH/LUTS 的风险。

总结

新出现的数据表明代谢综合征与 BPH/LUTS 之间存在很强的关系,表明存在共同的病因。进一步探索这种关系可能会导致对这些疾病的病理生理学、治疗和预防有新的认识。

相似文献

1
Lower urinary tract symptoms, obesity and the metabolic syndrome.下尿路症状、肥胖与代谢综合征。
Curr Opin Urol. 2010 Jan;20(1):7-12. doi: 10.1097/MOU.0b013e3283336f3f.
2
Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.肥胖与良性前列腺增生:临床关联、新兴病因学模式与未来方向。
J Urol. 2009 Dec;182(6 Suppl):S27-31. doi: 10.1016/j.juro.2009.07.086.
3
Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.当前良性前列腺增生症的治疗:对性功能的影响及相关性功能不良事件的管理。
Int J Clin Pract. 2011 Sep;65(9):1005-13. doi: 10.1111/j.1742-1241.2011.02731.x. Epub 2011 Jul 1.
4
Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.性功能障碍与下尿路症状/良性前列腺增生之间关系的最新进展。
Curr Opin Urol. 2006 Jan;16(1):11-9.
5
An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.一项亚洲多国针对良性前列腺增生患者的前瞻性观察性登记研究,重点关注合并症、下尿路症状和性功能。
BJU Int. 2008 Jan;101(2):197-202. doi: 10.1111/j.1464-410X.2007.07320.x. Epub 2007 Nov 13.
6
Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment.射精功能障碍及其与良性前列腺增生的下尿路症状和前列腺增生治疗的关联。
Urology. 2009 Jul;74(1):15-21. doi: 10.1016/j.urology.2008.06.048. Epub 2009 May 9.
7
Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia.磷酸二酯酶-5 抑制剂与良性前列腺增生。
Curr Opin Urol. 2010 Jan;20(1):49-54. doi: 10.1097/MOU.0b013e328333ac68.
8
Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology.下尿路症状与性功能障碍:流行病学与病理生理学
BJU Int. 2006 Apr;97 Suppl 2:23-8; discussion 44-5. doi: 10.1111/j.1464-410X.2006.06102.x.
9
Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients.代谢综合征对良性前列腺增生患者勃起功能障碍和下尿路症状的影响。
Aging Male. 2011 Mar;14(1):48-52. doi: 10.3109/13685538.2010.529197. Epub 2010 Nov 19.
10
Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.良性前列腺增生和下尿路症状的可改变风险因素:老问题的新方法
J Urol. 2007 Aug;178(2):395-401. doi: 10.1016/j.juro.2007.03.103. Epub 2007 Jun 11.

引用本文的文献

1
Continuation of Selective Alpha Blocker After Transurethral Resection of the Prostate Is Associated with a Decreased Risk of Hip Fractures in Elderly Patients Diagnosed with Benign Prostate Hyperplasia.经尿道前列腺切除术后继续使用选择性α受体阻滞剂与诊断为良性前列腺增生的老年患者髋部骨折风险降低相关。
Life (Basel). 2025 Apr 13;15(4):641. doi: 10.3390/life15040641.
2
Lower urinary tract symptoms among normal-weight, overweight, and obese palestinians: a study of prevalence and impact on the quality of life.巴勒斯坦正常体重、超重和肥胖人群的下尿路症状:患病率研究及其对生活质量的影响。
BMC Urol. 2024 Sep 13;24(1):199. doi: 10.1186/s12894-024-01587-5.
3
An evaluation of lower urinary tract symptoms among patients with hypertension: A cross-sectional study.
高血压患者下尿路症状的评估:一项横断面研究。
J Family Med Prim Care. 2024 Aug;13(8):3195-3202. doi: 10.4103/jfmpc.jfmpc_231_24. Epub 2024 Jul 26.
4
Methylglyoxal and Advanced Glycation End Products (AGEs): Targets for the Prevention and Treatment of Diabetes-Associated Bladder Dysfunction?甲基乙二醛与晚期糖基化终末产物(AGEs):预防和治疗糖尿病相关膀胱功能障碍的靶点?
Biomedicines. 2024 Apr 23;12(5):939. doi: 10.3390/biomedicines12050939.
5
Higher Physical Activity is Associated with Reduced Lower Urinary Tract Symptoms in Korean Men.较高的身体活动水平与韩国男性下尿路症状减轻有关。
World J Mens Health. 2025 Jan;43(1):166-173. doi: 10.5534/wjmh.230303. Epub 2024 Mar 20.
6
Age-Dependent Effects of Voluntary Wheel Running Exercise on Voiding Behavior and Potential Age-Related Molecular Mechanisms in Mice.年龄依赖性的自愿转轮运动对小鼠排尿行为和潜在的年龄相关分子机制的影响。
J Gerontol A Biol Sci Med Sci. 2024 Jun 1;79(6). doi: 10.1093/gerona/glae007.
7
Selenium in combination with a tomato lipid extract as a therapy for benign prostatic hyperplasia and its alterations in rats with induced BPH.硒与番茄脂质提取物联合用于治疗良性前列腺增生及其对诱导性良性前列腺增生大鼠的影响。
J Cell Mol Med. 2023 Oct;27(20):3147-3156. doi: 10.1111/jcmm.17903. Epub 2023 Sep 19.
8
A Spectrum of Age- and Gender-Dependent Lower Urinary Tract Phenotypes in Three Mouse Models of Type 2 Diabetes.2型糖尿病三种小鼠模型中一系列年龄和性别依赖性下尿路表型
Metabolites. 2023 May 31;13(6):710. doi: 10.3390/metabo13060710.
9
Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats.CB1 受体拮抗剂 AM6545 和 AM4113 对代谢综合征诱导的大鼠前列腺增生的影响。
Biomol Biomed. 2023 Nov 3;23(6):1069-1078. doi: 10.17305/bb.2023.9173.
10
Obesity, metabolic health, and urological disorders in adults: a nationwide population-based study.肥胖、代谢健康和成年人的泌尿科疾病:一项全国范围内基于人群的研究。
Sci Rep. 2021 Apr 22;11(1):8687. doi: 10.1038/s41598-021-88165-z.